Noxopharm investigates Covid-19 treatment

Drug developer Noxopharm is following up on indications that an experimental anti-cancer drug may be effective against the Covid-19 coronavirus. Melbourne’s Hudson Institute of Medical Research has identified anti-inflammatory properties of the experimental drug idronoxil, the active ingredient in the company’s anti-cancer drug candidate Veyonda. Pre-clinical models indicate the drug has the ability to treat…

Ansell on track despite coronavirus spread

Global protective glove manufacturer Ansell is one of the few large companies that has been able to reaffirm its profit projections for the year despite the Covid-19 coronavirus pandemic. The manufacturer of rubber industrial and surgical gloves told investors it was experiencing very strong demand for its AlphaTec hand and body chemical protection products. There…

New digital shipbuilding diploma launched

Australia’s first digital shipbuilding course has been launched to support the increased pace and sophistication of naval shipbuilding in Australia. With the federal government letting $90 billion in contracts for patrol boats, frigates and submarines, yards in Perth and Adelaide are increasingly digitally enabled. The BAE Systems yard being enlarged at Osborne in South Australasia…